Understanding Your Endocannabinoid System Through Scientific Research
Understanding the endocannabinoid system requires examining peer-reviewed scientific research rather than dismissing cannabis medicine entirely. Dr. Benjamin Caplan leads evidence-based cannabis care at CED Clinic, focusing on how endocannabinoid system…
Why some people may feel hungry after smoking weed – K24 Digital
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. THCResearchNeurologySafetyDosingMental HealthIndustry Why This Matters Understanding THC’s mechanism of action…
Left Exit 12 Off Ramp – CED Clinic
✦ New CED Clinical Relevance #80 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. SleepPainAnxietyMental HealthCBDTHCDosing Clinical Summary I cannot generate a clinical summary for this article as…
Cannabis Drug Interaction Check (Free) – Green Bridge Society
✦ New CED Clinical Relevance #81 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. SafetyDrug InteractionsMental HealthResearchCBDTHCDosing I apologize – I need to correct myself as “Drug…
Policy Watch: Key Synthetic Cannabinoids Schedule I Updates — June 02, 2026
This policy watch highlights synthetic cannabinoids Schedule I updates 2026 with significant clinical and regulatory implications. The DEA's recent actions classify several synthetic cannabinoids as Schedule I substances, affecting clinicians and…
THC Blood-Brain Barrier: Your Endocannabinoid System Waits Patiently
Your endocannabinoid system demonstrates remarkable patience while waiting for THC to cross the blood-brain barrier. Understanding this process helps explain why cannabis effects take time to manifest. This biological masterclass reveals the intricate…
Emerging Clinical Data on GLP-1 Receptor Agonists in Alcohol Use Disorder
GLP-1 receptor agonist alcohol use disorder clinical data reveals potential therapeutic effects beyond glycemic control. This emerging evidence suggests benefits in craving reduction and reward pathway modulation. Family medicine clinicians should…
GLP-1 Receptor Agonist Randomized Trial Results: MACE and Kidney Protection
GLP-1 receptor agonist kidney protection is a key finding in recent research involving type 1 diabetes patients. These agents demonstrate benefits beyond glycemic control, including cardiovascular and renal protection. Understanding these outcomes…
Understanding Weight Loss Maintenance After GLP-1 Therapy
Weight loss maintenance after GLP-1 therapy is a critical topic for patients and clinicians. Many individuals sustain significant weight loss even after stopping semaglutide or tirzepatide. This challenges assumptions about inevitable weight regain…
Comparing Semaglutide Dosing: Ozempic and Wegovy Clinical Evidence
This article reviews semaglutide dosing comparison between Ozempic and Wegovy. Understanding these differences is crucial for clinicians prescribing GLP-1 receptor agonists. Semaglutide dosing comparison informs appropriate treatment decisions and…